Primary sclerosing cholangitis screening

Primary sclerosing cholangitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Primary sclerosing cholangitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Primary sclerosing cholangitis screening On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Primary sclerosing cholangitis screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Primary sclerosing cholangitis screening
CDC on Primary sclerosing cholangitis screening
Primary sclerosing cholangitis screening in the news
Blogs on Primary sclerosing cholangitis screening
Directions to Hospitals Treating Primary sclerosing cholangitis
Risk calculators and risk factors for Primary sclerosing cholangitis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Screening

PSC is associated with cholangiocarcinoma, which are tumors involving the biliary tree. Screening for cholangiocarcinoma in patients with PSC is encouraged, but there is no general consensus on the modality and interval of choice.